Evidence map›Paper›PMID 31248071›Full record

ReviewInternational journal of molecular sciences2019

Role of the Ubiquitin Proteasome System (UPS) in the HIV-1 Life Cycle.

Vivian K Rojas, In-Woo Park

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. An mNature communications · 2025
    Article
  5. Article
  6. The Magic and Mystery of TRIM65 in Diseases.Current medicinal chemistry · 2025
    Review
  7. Functional 20S Proteasomes in Retroviruses: Evidence in Favor.International journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Proteasomal Inhibition Potentiates Latent HIV Reactivation.AIDS research and human retroviruses · 2020
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Vivian K RojasDepartment of Microbiology, Immunology, and Genetics, University of North Texas, Health Science Center, Fort Worth, TX 76107, USA. vivian.rojas@unthsc.edu.
In-Woo ParkDepartment of Microbiology, Immunology, and Genetics, University of North Texas, Health Science Center, Fort Worth, TX 76107, USA. inwoo.park@unthsc.edu.
University of North Texas · USUniversity of North Texas Health Science Center · US

Funding

Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver DiseaseR01DK099055 · NIDDK · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI PARK, IN-WOO · 2014 to 2017
$1.4M
NIH/NIDDK NIH/NIDDK R01 DK099055
6 · The paper itself

Abstract

Given that the ubiquitin proteasome system (UPS) is the major protein degradation process in the regulation of a wide variety of cellular processes in eukaryotic cells, including alteration of cellular location, modulation of protein activity, and regulation of protein interaction, it is reasonable to suggest that the infecting HIV-1 and the invaded hosts exploit the UPS in a contest for survival and proliferation. However, to date, regulation of the HIV-1 life cycle has been mainly explained by the stage-specific expression of HIV-1 viral genes, not by elimination processes of the synthesized proteins after completion of their duties in the infected cells, which is also quintessential for understanding the molecular processes of the virus life cycle and thereby HIV-1 pathogenesis. In fact, several previous publications have indicated that the UPS plays a critical role in the regulation of the proteasomal degradation of viral and cellular counterparts at every step of the HIV-1 life cycle, from the virus entry to release of the assembled virus particles, which is integral for the regulation of survival and proliferation of the infecting HIV-1 and to replication restriction of the invading virus in the host. However, it is unknown whether and how these individual events taking place at different stages of the HIV-1 life cycle are orchestrated as an overall strategy to overcome the restrictions conferred by the host cells. Thus, in this review, we overview the interplay between HIV-1 viral and cellular proteins for restrictions/competitions for proliferation of the virus in the infected cell, which could open a new avenue for the development of therapeutics against HIV-1 via targeting a specific step of the proteasome degradation pathway during the HIV-1 life cycle.

Indexed as

Virus ReplicationHIV-1HIV InfectionsHumansLife Cycle StagesProteasome Endopeptidase ComplexProteolysisUbiquitinProteasome Endopeptidase ComplexUbiquitinE3 ligaseHIV-1HIV-1 viral proteinsproteasomal degradationubiquitinubiquitin proteasome system

Identifiers

PMID31248071
PMCPMC6628307
OpenAlexW2949141518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.